With the announcement that Jeff Berg is the new president of AbelsonTaylor, Med Ad News took the opportunity to ask Berg a few questions.
While a number of factors are constraining the usefulness of AI tools for pharma marketers, experts believe that the use and sophistication of these tools will evolve.
Pharma companies may not like their products being the subject of ICER reports, but they can provide a jumping-off point for manufacturers to expand the conversation of the value of new medicines in the rare disease area.
Soon after his departure from FCB Health during April 2019, Rich Levy had a new job; as chief creative officer of Klick Health. In the wake of Levy’s departure, Dana Maiman – president and CEO of FCB Health Network – announced that Kathleen Nanda was promoted to executive creative director of FCB Health New York.
The healthcare ad industry continues to thrive and adapt to the new demands for relevance and creativity.
For various agencies featured in this annual report, 2018 and the beginning of 2019 were not business as usual but rather filled with rebrandings, reorganizations, and new offerings.
In the past 15 months, agencies of all sizes featured in this annual report were active in finding and hiring new talent.
One is going, one is staying – and getting a promotion.
With Congressional hearings on drug prices, proposed rules for Medicare plans and new ICER efforts to link outcomes to value, finding answers on how to price and pay for drugs is still difficult.